Shanghai Shyndec Pharmaceutical's (SHA:600420) unit, Sinopharm Industrial, received a drug registration certificate from China's National Medical Products Administration for penehyclidine hydrochloride injection, according to a Shanghai bourse filing on Friday.
The drug is used as a pre-anesthetic medication and as an emergency treatment of organophosphorus poisoning.